Therapy of intracranial hypertension in patients with fulminant hepatic failure

Neurocritical Care

Volumn 4, Issue 2, 2006, Pages 179-189

  Raghavan, Murugan ^a   Marik, Paul E ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Acute liver failure; Critically ill; Fulminant hepatic failure; Intensive care unit; Intracerebral pressure; Intracranial hypertension; Therapy

Indexed keywords

AMMONIA; BARBITURIC ACID DERIVATIVE; BIOCHEMICAL MARKER; GLUTAMINE; INDOMETACIN; MANNITOL; PENTOBARBITAL; POTASSIUM CHANNEL; PROPOFOL; SODIUM CHLORIDE; THIOPENTAL;

ASSISTED VENTILATION; BIOARTIFICIAL LIVER; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; BRAIN METABOLISM; CLINICAL FEATURE; CLINICAL TRIAL; COMA; DOPPLER ECHOGRAPHY; DRUG SAFETY; DYNAMICS; EARLY DIAGNOSIS; ELECTROENCEPHALOGRAPHY; ENERGY METABOLISM; GASTROINTESTINAL HEMORRHAGE; HEART DISEASE; HEPATOCYTE TRANSPLANTATION; HUMAN; HYPERVENTILATION; HYPOTENSION; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTESTINE ISCHEMIA; INTRACRANIAL HYPERTENSION; JUGULAR VEIN; LIVER FAILURE; LIVER RESECTION; LIVER TRANSPLANTATION; MONITORING; MORTALITY; NEPHROTOXICITY; NEUROTRANSMISSION; NONHUMAN; OXIDATION; OXIMETRY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SURVIVAL; THROMBOCYTE DYSFUNCTION; TREATMENT OUTCOME; VASODILATATION;

AMMONIA; ANESTHETICS, INTRAVENOUS; BRAIN; CARDIOVASCULAR AGENTS; CEREBROVASCULAR CIRCULATION; ELECTROENCEPHALOGRAPHY; GLUTAMINE; HUMANS; HYPERVENTILATION; HYPOTHERMIA, INDUCED; INDOMETHACIN; INTRACRANIAL HYPERTENSION; LIVER FAILURE, ACUTE; PROPOFOL; VASODILATION;

EID: 33646919885     PISSN: 15416933     EISSN: None     Source Type: Journal    
DOI: 10.1385/NCC:4:2:179     Document Type: Review

References (113)

1. Hoofnagle JH, Carithers RL Jr, Shapiro C, Ascher N. Fulminant hepatic failure: summary of a workshop. Hepatology 1995;21:240-252.
2. Ostapowicz G, Fontana RJ, Schiodt FV, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002;137:947-954.
3. O'Grady JG. Paracetamol hepatotoxicity: how to prevent. J R Soc Med 1997;90:368-370.
4. Butterworth RF. Molecular neurobiology of acute liver failure. Semin Liver Dis 2003;23:251-258.
5. Blei AT. The pathophysiology of brain edema in acute liver failure. Neurochem Int 2005;47:71-77.
6. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int 2005;47:78-83.
7. Blei AT. Medical therapy of brain edema in fulminant hepatic failure. Hepatology 2000;32:666-669.
8. Blei AT. Cerebral edema and intracranial hypertension in acute liver failure: distinct aspects of the same problem. Hepatology 1991;13:376-379.
9. Larsen FS, Adel HB, Pott F, et al. Dissociated cerebral vasoparalysis in acute liver failure. A hypothesis of gradual cerebral hyperaemia. J Hepatol 1996;25:145-151.
10. Blei AT, Larsen FS. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 1999;31:771-776.
11. Blei AT. Pathophysiology of brain edema in fulminant hepatic failure, revisited. Metab Brain Dis 2001;16:85-94.
12. Ott P, Larsen FS. Blood-brain barrier permeability to ammonia in liver failure: a critical reappraisal. Neurochem Int 2004;44:185-198.
13. Felipo V, Butterworth RF. Neurobiology of ammonia. Prog Neurobiol 2002;67:259-279.
14. Norenberg MD. Oxidative and nitrosative stress in ammonia neurotoxicity. Hepatology 2003;37:245-248.
15. Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999;29:648-653.
16. Strauss GI, Knudsen GM, Kondrup J, Moller K, Larsen FS. Cerebral metabolism of ammonia and amino acids in patients with fulminant hepatic failure. Gastroenterology 2001;121:1109-1119.
17. Cordoba J, Gottstein J, Blei AT. Chronic hyponatremia exacerbates ammonia-induced brain edema in rats after portacaval anastomosis. J Hepatol 1998;29:589-594.
18. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994;19:1437-1444.
19. Rao KV, Norenberg MD. Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia. Metab Brain Dis 2001;16:67-78.
20. Chatauret N, Rose C, Therrien G, Butterworth RF. Mild hypothermia prevents cerebral edema and CSF lactate accumulation in acute liver failure. Metab Brain Dis 2001;16:95-102.
21. Belanger M, Chan H, Hazell AS, Butterworth RF. Increased lactate dehydrogenase (LDH) expression and activity in cultured astrocytes exposed to ammonia. J Neurochem 2001;78(Suppl 1):25.
22. Hilgier W, Zielinska M, Borkowska HD, et al. Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure. J Neurosci Res 1999;56:76-84.
23. Chatauret N, Zwingmann C, Rose C, Leibfritz D, Butterworth RF. Effects of hypothermia on brain glucose metabolism in acute liver failure: a H/C-nuclear magnetic resonance study. Gastroenterology 2003;125:815-824.
24. Tofteng F, Jorgensen L, Hansen BA, Ott P, Kondrup J, Larsen FS. Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 2002;36:1333-1340.
25. Larsen FS, Ejlersen E, Clemmesen JO, Kirkegaard P, Hansen BA. Preservation of cerebral oxidative metabolism in fulminant hepatic failure: an autoregulation study. Liver Transpl Surg 1996;2:348-353.
26. Durham S, Yonas H, Aggarwal S, Darby J, Kramer D. Regional cerebral blood flow and CO2 reactivity in fulminant hepatic failure. J Cereb Blood Flow Metab 1995;15:329-335.
27. Aggarwal S, Kramer D, Yonas H, et al. Cerebral hemodynamic and metabolic changes in fulminant hepatic failure: a retrospective study. Hepatology 1994;19:80-87.
28. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994;19:1407-1413.
29. Livingstone AS, Potvin M, Goresky CA, Finlayson MH, Hinchey EJ. Changes in the blood-brain barrier in hepatic coma after hepatectomy in the rat. Gastroenterology 1977;73:697-704.
30. Vaquero J, Chung C, Blei AT. Cerebral blood flow in acute liver failure: a finding in search of a mechanism. Metab Brain Dis 2004;19:177-194.
31. Yang ST, Chang HH. Nitric oxide of neuronal origin mediates NMDA-induced cerebral hyperemia in rats. Neuroreport 1998;9:415-418.
32. Hermenegildo C, Monfort P, Felipo V. Activation of N-methyl-D-aspartate receptors in rat brain in vivo following acute ammonia intoxication: characterization by in vivo brain microdialysis. Hepatology 2000;31:709-715.
33. Moore PK, Handy RL. Selective inhibitors of neuronal nitric oxide synthase-is no NOS really good NOS for the nervous system? Trends Pharmacol Sci 1997;18:204-211.
34. Iadecola C, Pelligrino DA, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab 1994;14:175-192.
35. Song G, Dhodda VK, Blei AT, Dempsey RJ, Rao VL. GeneChip analysis shows altered mRNA expression of transcripts of neurotransmitter and signal transduction pathways in the cerebral cortex of portacaval shunted rats. J Neurosci Res 2002;68:730-737.
36. Harder DR, Lange AR, Gebremedhin D, Birks EK, Roman RJ. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue. J Vasc Res 1997;34:237-243.
37. Jalan R. Intracranial hypertension in acute liver failure: pathophysiological basis of rational management. Semin Liver Dis 2003;23:271-282.
38. Ascher NL, Lake JR, Emond JC, Roberts JP. Liver transplantation for fulminant hepatic failure. Arch Surg 1993;128:677-682.
39. Abdo A, Lopez O, Fernandez A, et al. Transcranial Doppler sonography in fulminant hepatic failure. Transplant Proc 2003;35:1859-1860.
40. Strauss GI, Moller K, Holm S, Sperling B, Knudsen GM, Larsen FS. Transcranial Doppler sonography and internal jugular bulb saturation during hyperventilation in patients with fulminant hepatic failure. Liver Transpl 2001;7:352-358.
41. Bass NM. Monitoring and treatment of intracranial hypertension. Liver Transpl 2000;6(4 Suppl 1):S21-S26.
42. Hanid MA, Davies M, Mellon PJ, et al. Clinical monitoring of intracranial pressure in fulminant hepatic failure. Gut 1980;21:866-869.
43. Ellis A, Wendon J. Circulatory, respiratory, cerebral, and renal derangements in acute liver failure: pathophysiology and management. Semin Liver Dis 1996;16:379-388.
44. Toftengi F, Larsen FS. Management of patients with fulminant hepatic failure and brain edema. Metab Brain Dis 2004;19:207-214.
45. Donovan JP, Shaw BW Jr, Langnas AN, Sorrell MF. Brain water and acute liver failure: the emerging role of intracranial pressure monitoring. Hepatology 1992;16:267-268.
46. McCashland TM, Shaw BW Jr, Tape E. The American experience with transplantation for acute liver failure. Semin Liver Dis 1996;16:427-433.
47. Davies MH, Mutimer D, Lowes J, Elias E, Neuberger J. Recovery despite impaired cerebral perfusion in fulminant hepatic failure. Lancet 1994;343:1329-1330.
48. Cordoba J, Blei AT. Cerebral edema and intracranial pressure monitoring. Liver Transpl Surg 1995;1:187-194.
49. Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993;341:157-158.
50. Shami VM, Caldwell SH, Hespenheide EE, Arseneau KO, Bickston SJ, Macik BG. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy. Liver Transpl 2003;9:138-143.
51. Larsen FS. Cerebral circulation in liver failure: Ohm's law in force. Semin Liver Dis 1996;16:281-292.
52. Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 2004;39:471-475.
53. Nielsen HB, Tofteng F, Wang LP, Larsen FS. Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure. J Hepatol 2003;38:188-192.
54. Cordoba J, Alonso J, Rovira A, et al. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001;35:598-604.
55. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000;32:536-541.
56. Shah V, Webster S, Gottstein J, Blei AT. Reduction of cerebral perfusion precedes rise of intracranial pressure in rats with ischemic fulminant liver failure. Hepatology 1993;17:1117-1122.
57. Butterworth RF. Hepatic encephalopathy and brain edema in acute hepatic failure: does glutamate play a role? Hepatology 1997;25:1032-1034.
58. Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. J Hepatol 2004;41:89-96.
59. Strauss GI, Christiansen M, Moller K, Clemmesen JO, Larsen FS, Knudsen GM. S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transplantation 2001;7:964-970.
60. Strauss GI, Edvinsson L, Larsen FS, Moller K, Knudsen GM. Circulating levels of neuropeptides (CGRP, VIP, NPY) in patients with fulminant hepatic failure. Neuropeptides 2001;35:174-180.
61. Mansel JK, Stogner SW, Petrini MF, Norman JR. Mechanical ventilation in patients with acute severe asthma. Am J Med 1990;89:42-48.
62. Williams TJ, Tuxen DV, Scheinkestel CD, Czarny D, Bowes G. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis 1992;146:607-615.
63. Chatauret N, Rose C, Butterworth RF. Mild hypothermia in the prevention of brain edema in acute liver failure: mechanisms and clinical prospects. Metab Brain Dis 2002;17:445-451.
64. Rose C, Michalak A, Pannunzio M, Chatauret N, Rambaldi A, Butterworth RF. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000;31:872-877.
65. Jalan R, Rose C. Hypothermia in acute liver failure. Metab Brain Dis 2004;19:215-221.
66. Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Restoration of cerebral blood flow autoregulation and reactivity to carbon dioxide in acute liver failure by moderate hypothermia. Hepatology 2001;34:50-54.
67. Jalan R, Olde Damink SW, Deutz NE, Hayes PC, Lee A. Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 2004;127:1338-1346.
68. Strauss GI, Hogh P, Moller K, Knudsen GM, Hansen BA, Larsen FS. Regional cerebral blood flow during mechanical hyperventilation in patients with fulminant hepatic failure. Hepatology 1999;30:1368-1373.
69. Strauss G, Hansen BA, Knudsen GM, Larsen FS. Hyperventilation restores cerebral blood flow autoregulation in patients with acute liver failure. J Hepatol 1998;28:199-203.
70. Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986;2:43-51.
71. Marik P, Chen K, Varon J, Fromm RE, Sternbach GL. Management of increased intracranial pressure: a review for clinicians. J Emerg Med 1999;17:711-719.
72. Marik PE. Propofol: therapeuric indications and side effects. Curr Pharm Design 2004;10:3639-3649.
73. Veroli P, O'Kelly B, Bertrand F, Trouvin JH, Farinotti R, Ecoffey C. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation. Br J Anaesth 1992;68:183-186.
74. Fulton B, Sorkin EM. Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;50:636-657.
75. Bao YP, Williamson G, Tew D, et al. Antioxidant effects of propofol in human hepatic microsomes: concentration effects and clinical relevance. Br J Anaesth 1998;81:584-589.
76. Stephan H, Sonntag H, Schenk HD, Kohlhausen S. Effect of Disoprivan (propofol) on the circulation and oxygen consumption of the brain and CO2 reactivity of brain vessels in the human. Anaesthesist 1987;36:60-65.
77. Hartung HJ. Intracranial pressure in patients with craniocerebral trauma after administration of propofol and thiopental. Anaesthesist 1987;36:285-287.
78. Hartung HJ. Modification of intracranial pressure by propofol (Disoprivan). Initial results. Anaesthesist 1987;36:66-68.
79. Ravussin P, Guinard JP, Ralley F, Thorin D. Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy. Anaesthesia 1988;43(Suppl): 37-41.
80. Vandesteene A, Trempont V, Engelman E, et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988;43(Suppl):42-43.
81. Enns J, Gelb AW, Manninen PH. Cerebral autoregulation is maintained during propofol-nitrous oxide anaesthesia in humans. Can J Anaes 1992;39:A43.
82. Jansen GF, Kagenaar D, Kedaria MB. Effects of propofol on the relation between CO2 and cerebral blood flow velocity. Anesth Analg 1993;76:S163.
83. Newman MF, Murkin JM, Roach G, et al. Cerebral physiologic effects of burst suppression doses of propofol during nonpulsatile cardiopulmonary bypass. CNS Subgroup of McSPI. Anesth Analg 1995;81:452-457.
84. Kochs E, Hoffman WE, Werner C, Thomas C, Albrecht RF, Schulte EJ. The effects of propofol on brain electrical activity, neurologic outcome, and neuronal damage following incomplete ischemia in rats. Anesthesiol 1992;76:245-252.
85. Gelb AW, Zhang C, Henderson SM. A comparison of the cerebral protective effects of propofol, thiopental, and halothane in temporary feline focal cerebral ischemia. Anesth Analg 1993;76:S115.
86. Ridenour TR, Warner DS, Todd MM, Gionet TX. Comparative effects of propofol and halothane on outcome from temporary middle cerebral artery occlusion in the rat. Anesthesiol 1992;76:807-812.
87. Ito H, Watanabe Y, Isshiki A, Uchino H. Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABAA receptors. Acta Anaesthesiol Scand 1999;43:153-162.
88. Velly LJ, Guillet BA, Masmejean FM, et al. Neuroprotective effects of propofol in a model of ischemic cortical cell cultures: role of glutamate and its transporters. Anesthesiol 2003;99:368-375.
89. Sagara Y, Hendler S, Khoh-Reiter S, et al. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 1999;73:2524-2530.
90. Ergun R, Akdemir G, Sen S, Tasci A, Ergungor F. Neuroprotective effects of propofol following global cerebral ischemia in rats. Neurosurgical Review 2002;25:95-98.
91. Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc 2002;34:1220-1222.
92. Qureshi AI, Wilson DA, Traystman RJ. Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism. J Neursurg Anesthesiol 2002;14:22-30.
93. Qureshi AI, Suarez JI. Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension. Crit Care Med 2000;28:3301-3313.
94. Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004;10:126-131.
95. Peterson B, Khanna S, Fisher B, Marshall L. Prolonged hypernatremia controls elevated intracranial pressure in head-injured pediatric patients. Crit Care Med 2000;28:1136-1143.
96. Toung TJ, Tyler B, Brem H, Traystman RJ, Hum PD, Bhardwaj A. Hypertonic saline ameliorates cerebral edema associated with experimental brain tumor. J Neursurg Anesthesiol 2002;14:187-193.
97. Wisner DH, Schuster L, Quinn C. Hypertonic saline resuscitation of head injury: effects on cerebral water content. J Trauma 1990;30:75-78.
98. Jensen K, Ohrstrom J, Cold GE, Astrup J. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension. Acta Neurochirurgica 1991;108:116-121.
99. Shackford SR, Schmoker JD, Zhuang J. The effect of hypertonic resuscitation on pial arteriolar tone after brain injury and shock. J Trauma 1994;37:899-908.
100. Nakayama S, Kramer GC, Carlsen RC, Holcroft JW. Infusion of very hypertonic saline to bled rats: membrane potentials and fluid shifts. J Surg Res 1985;38:180-186.
101. Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004;39:464-470.
102. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982;23:625-629.
103. Dahl B, Bergholt B, Cold GE, et al. CO(2) and indomethacin vasoreactivity in patients with head injury. Acta Neurochirurgica 1996;138:265-273.
104. Jensen K, Freundlich M, Bunemann L, Therkelsen K, Hansen H, Cold GE. The effect of indomethacin upon cerebral blood flow in healthy volunteers. The influence of moderate hypoxia and hypercapnia. Acta Neurochirurgica 1993;124:114-119.
105. Chung C, Gottstein J, Blei AT. Indomethacin prevents the development of experimental ammonia-induced brain edema in rats after portacaval anastomosis. Hepatology 2001;34:249-254.
106. Tofteng F, Larsen FS. The effect of indomethacin on intracranial pressure, cerebral perfusion and extracellular lactate and glutamate concentrations in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2004;24:798-804.
107. Clemmesen JO, Hansen BA, Larsen FS. Indomethacin normalizes intracranial pressure in acute liver failure: a twenty-three-year-old woman treated with indomethacin. Hepatology 1997;26:1423-1425.
108. Forbes A, Alexander GJ, O'Grady JG, et al. Thiopental infusion in the treatment of intracranial hypertension complicating fulminant hepatic failure. Hepatology 1989;10:306-310.
109. Strom SC, Fisher RA, Thompson MT, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997;63:559-569.
110. Samuel D, Ichai P, Feray C, et al. Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. Transplantation 2002;73:257-264.
111. Bismuth H, Samuel D, Castaing D, Williams R, Pereira SP. Liver transplantation in Europe for patients with acute liver failure. Semin Liver Dis 1996;16:415-425.
112. Jalan R, Pollok A, Shah SH, Madhavan K, Simpson KJ. Liver derived pro-inflammatory cytokines may be important in producing intracranial hypertension in acute liver failure. J Hepatol 2002;37:536-538.
113. Ringe B, Lubbe N, Kuse E, Frei U, Pichlmayr R. Total hepatectomy and liver transplantation as two-stage procedure. Ann Surg 1993;218:3-9.